This list compares their: Medication : Primary Use // Frequency // Starting Dose // Maximum Amount Ozempic: Type 2 Diabetes // Once Weekly // 0.25 mg // 2.0 mg Wegovy : Weight Loss // Once Weekly // 0.25 mg // 2.4 mg up to 7.2 mg* T irzepatide(Mounjaro / Zepbound): Diabetes & Weight Loss // Once Weekly // 2.5 mg // 15.0 mg Retatrutide (Phase 3 Trials): Weight Loss (Investigational) // Once Weekly // 2.0 mg // 12.0 mg Effectivness Comparing data from Retatrutide clinical trials shows it to be significantly more effective for weight loss when compared to previous GLP-1 medications
Our dedicated medical team takes the time to educate and guide you, ensuring you understand the difference between naturally occurring GLP-1 and pharmaceutical interventions designed to enhance your health
This translated into 12 fewer serious harm events per 1,000 GLP-1 users
Requires the most commitment (7 injections weekly) and is typically reserved for those highly sensitive to GLP-1 side effects
Where is compounded tirzepatide produced
Accordingly, despite losing 25% of their body mass, GLP-1MK-801-treated mice maintained an energy expenditure that was similar to that of vehicle-treated control mice and was therefore also significantly higher than the gradually decreasing energy expenditure observed in mice that were calorie-restricted to match the weight loss trajectory of GLP-1MK-801-treated mice
